Northwest Biotherapeutics CEO Linda Powers' 2019 pay falls 92% to $602K
Northwest Biotherapeutics reports 2019 executive compensation
By ExecPay News
Published: March 27, 2020
Northwest Biotherapeutics reported fiscal year 2019 executive compensation information on March 27, 2020.
In 2019, five executives at Northwest Biotherapeutics received on average a compensation package of $460K, a 87% decrease compared to previous year.
Average pay of disclosed executives at Northwest Biotherapeutics
Linda F. Powers, Chief Executive Officer, received $602K in total, which decreased by 92% compared to 2018. 83% of Powers' compensation, or $502K, was in salary. Powers also received $100K in bonus.
Jean M. Davis, Chief Financial Officer, received a compensation package of $516K. 97% of the compensation package, or $500K, was in option awards.
Leslie Goldman, General Counsel, earned $442K in 2019, a 90% decrease compared to previous year.
Marnix L. Bosch, Chief Technical Officer, received $397K in 2019, which decreases by 37% compared to 2018.
Alton L. Boynton, Chief Scientific Officer, earned $345K in 2019, a 81% decrease compared to previous year.
Related executives
Linda Powers
Northwest Biotherapeutics
Chief Executive Officer
Alton Boynton
Northwest Biotherapeutics
Chief Scientific Officer
Leslie Goldman
Northwest Biotherapeutics
General Counsel
Marnix Bosch
Northwest Biotherapeutics
Chief Technical Officer
Jean Davis
Northwest Biotherapeutics
Chief Financial Officer
You may also like
Source: SEC filing on March 27, 2020.